Trademark: 88862099
Status Date
Monday, October 23, 2023
Filing Date
Tuesday, April 7, 2020
Published for Opposition
Tuesday, July 26, 2022
Abandoned Date
Monday, October 23, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Oct 23, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 23, 2023
Abandonment - No Use Statement Filed
Mar 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2023
Sou Extension 1 Granted
Mar 15, 2023
Sou Extension 1 Filed
Mar 15, 2023
Sou Teas Extension Received
Sep 20, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 17, 2022
Suspension Checked ¿ To Attorney For Action
Jun 17, 2022
Approved For Pub - Principal Register
May 27, 2022
Suspension Checked ¿ To Attorney For Action
Apr 20, 2022
Suspension Checked ¿ To Attorney For Action
Jan 24, 2022
Suspension Checked ¿ To Attorney For Action
Jul 6, 2021
Report Completed Suspension Check Case Still Suspended
Jan 6, 2021
Report Completed Suspension Check Case Still Suspended
Jun 19, 2020
Notification Of Letter Of Suspension E-Mailed
Jun 19, 2020
Letter Of Suspension E-Mailed
Jun 19, 2020
Suspension Letter Written
Jun 15, 2020
Assigned To Examiner
Apr 14, 2020
New Application Office Supplied Data Entered
Apr 10, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
